Reduced Col2a1/col2a1 gene expression is a feature of both experimental models and may be responsible for overlapping clinical manifestations of patients with SEMD and those with diseases classically attributed to type‐2 collagen defects [82]. Here, COL2A1 is linked to spondyloepimetaphyseal dysplasia.